(Q34155425)

31 July 2017

1 reference

title

Predictors of outcome in cancer patients with candidemia (English)

1 reference

31 July 2017

1 reference

O Uzun

1

1 reference

PubMed ID

11205457

31 July 2017

E J Anaissie

series ordinal

2

1 reference

31 July 2017

1 December 2000

1 reference

31 July 2017

1 reference

31 July 2017

11

1 reference

31 July 2017

12

1 reference

31 July 2017

1517-1521

1 reference

Predominant pathogens in hospital infections

31 July 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Major trends in the microbial etiology of nosocomial infection.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Nosocomial fungemia in a large community teaching hospital

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Fungemia in patients with leukemia.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Risk factors for death among cancer patients with fungemia.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Predictors of adverse outcome in cancer patients with candidemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Correlation between in vitro and in vivo activity of antifungal agents against Candida species

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008308923252

7 January 2021

Identifiers

DOI

10.1023/A:1008308923252

1 reference

31 July 2017

1 reference

PubMed ID

11205457